Director Jeffery S. Thompson to retire; John B. Henneman appointed Board Chair

Anika Therapeutics, Inc.

Jeffery S. Thompson will retire from Anika's Board at the 2024 Annual Meeting after 13 years.
John B. Henneman, III, an independent director since 2020, appointed Board Chair effective immediately.
Thompson's retirement not due to any disagreement with the Company's operations, policies, or practices.
Board will have seven directors after Thompson's departure; two Class I directors to be elected at Annual Meeting.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John B. Henneman, III

Chair of the Board

ANIK · Anika Therapeutics, Inc.

Effective: 2024-02-26
Filed: February 26, 2024, 6:59 PM ET

In connection with Mr. Thompson’s planned retirement, John B. Henneman, III, an independent director of the Company’s Board since 2020, has been appointed Chair of the Board, effective immediately.

Departed

Jeffery S. Thompson

Director

ANIK · Anika Therapeutics, Inc.

Filed: February 26, 2024, 6:59 PM ET

On February 24, 2024, Jeffery S. Thompson notified Anika Therapeutics, Inc. (the “Company”) of his intention to retire from the Board of Directors (the “Board”) after 13 years of dedicated service at the end of his current term.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John B. Henneman, III was appointed as Chair of the Board at Anika Therapeutics, Inc..

Action: appointed
Role: Chair of the Board

Exact text from the filing

In connection with Mr. Thompson’s planned retirement, John B. Henneman, III, an independent director of the Company’s Board since 2020, has been appointed Chair of the Board, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffery S. Thompson departed as Director at Anika Therapeutics, Inc..

Action: retire
Role: Director

Exact text from the filing

On February 24, 2024, Jeffery S. Thompson notified Anika Therapeutics, Inc. (the “Company”) of his intention to retire from the Board of Directors (the “Board”) after 13 years of dedicated service at the end of his current term.

View on SEC.gov

Anika Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001171843-24-000972

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.